Continue to Site

23andme

November 1, 2018 By Danielle Kirsh

FDA clears 23andMe for pharmacogenetics testing

April 21, 2017 By Chris Newmarker

23andMe is back: FDA allows marketing of genetic health risk tests

Market Summary > Current Price

The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Search Medical Design & Outsourcing